馃嚭馃嚫路1d agoResearchTier 1 路 Trial registry
NCT05692180: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma
Study type: INTERVENTIONAL. Phase: PHASE3.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- September 28, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE3.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Evidence: Tier 1 路 Trial registry
Related coverage
More related coverage
CU Anschutz Medical/17h ago
AB Nexus Awards $825,000 to Five CU Anschutz-CU Boulder Research Teams
UNLP Health Sciences/17h ago
Nueva l铆nea universitaria de colaciones saludables
UNLP Health Sciences/17h ago
La UNLP escal贸 213 posiciones en el ranking mundial de sostenibilidad
OrbiMed/17h ago